NSE filing. Summary written from the filing by ALFA Finder's alert engine.
Docmode Health Technologies Limited: key numbers
- Share price
- ₹22.05
- Market cap
- ₹6.93 Cr
- Revenue (annual)
- ₹25.52 Cr
- Net profit (annual)
- ₹-0.13 Cr
- P/E (TTM)
- -51.4×Sector 34.0×
- Promoter holding
- 29.50%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Docmode Health Technologies Limited
All →Docmode Health Technologies Capital Structure Change
Ramesh Kumar Jain and Ramesh Jain HUF net acquired 20,000 DHTL shares on the open market, raising PAC stake to 11.45%. This SAST Reg 29(2) disclosure reflects a minor stake increase.
Docmode Health Technologies Annual General Meeting
Doctrack Solutions Limited conducted its 9th Annual General Meeting on September 30, 2026. Shareholders considered the adoption of audited financial statements and approved related party transactions.
Docmode Health Technologies Annual General Meeting
Docmode Health Technologies Limited issued the notice for its Annual General Meeting scheduled for September 30, 2026. The agenda includes financial statement adoption and RPT approval.
Docmode Health Technologies H2 FY26 Results: Net Loss of ₹0.1 Cr, Loss Narrows
Docmode Health Technologies Limited reported revenue from operations of ₹7.7 Cr (-64.0% YoY) and a net loss of ₹0.1 Cr for H2 FY26.
- Key figure
- Net loss ₹0.1 Cr
Docmode Health Technologies Board Meeting Date
Doctrack Solutions Limited has rescheduled its board meeting to September 4, 2026. The board will consider and approve audited financial results for the half-year ended March 2026.
Docmode Health Technologies Other Announcement
DocMode Health Technologies Limited has changed its name to Doctrack Solutions Limited. The company has formally altered its Memorandum and Articles of Association accordingly.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.